Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
Kenvue Beats First-Quarter Estimates Amid Pending Acquisition by Kimberly-Clark
Related Posts
Add A Comment
Usefull Links
Articles
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
© 2026 smsanews.com. All rights reserved. Designed by DD.

